The stroke clinical program is probably too far ahead of HIE for HIE to be approved first.
So very unlikely to be awarded a priority review voucher.
Still great endorsement/validation from the FDA for the pre-clinical work done to-date.
The stroke clinical program is probably too far ahead of HIE for...
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $71.84M | |||
| Open | High | Low | Value | Volume |
| 58.5¢ | 60.0¢ | 57.0¢ | $169.5K | 294.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.0¢ | 3209 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
58.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 57.0¢ | 60.0¢ | 57.0¢ | 33870 | ||
| Last updated 15.56pm 03/05/2024 ? | |||||
| AGN (ASX) Chart |